Skip to content

2019

IP pharma challenges in 2019

In connection to the publication of a new issue of the Stockholm Intellectual Property Law Review, where our researcher Marcus Holgersson serves on the board of directors, a seminar on IP pharma challenges in 2019 was held in Stockholm on June 4, 2019. The seminar covered several important topics, including the use of and uncertainty related to doctrines of equivalents, the opportunities and risks with CRISPR-Cas9 gene editing technologies, and branding and trademarking pharmaceuticals. Much more can be read about these topics in the latest issue of Stockholm Intellectual Property Law Review, available here.

The seminar was followed by a dinner, celebrating the recent graduates of the IP Law master program of Stockholm University. We wish the students best of luck with their future careers in the IP Law field.


Thomas Hedner from IMIT giving a thought-provoking talk on the opportunities and risks with CRISPR-Cas9
Kristina Björnerstedt from Skriptor Zigila talking about the structured process of naming your business, product, or pharmaceutical

John Hornby from Lambert Hornby Ltd talking about the doctrine of equivalents from a UK perspective

Bengt Domeij from Uppsala University giving a Swedish perspective, also on the doctrine of equivalents
Students celebrated by parts of the Swedish IP community

Recent talks delivered by Ove Granstrand

Professor Ove Granstrand has during the spring held several fascinating talks on the theme: ”Do patents and innovations contribute to growth and welfare?”

Following up on his first Leverhulme Trust Lecture held in December on the Nobel Laureates in Economics’ work on Technology, IP, Innovation and Growth, Granstrand focused his second talk on presenting some of his own research from his recently published book within the area. The talk covered topics such as the innovation spiral and the links between its variables, the critiques of and motives behind the patent system and some global challenges with the needs for institutional innovations to manage them. Astra’s medical drug Losec and the role of patenting and evergreening strategy in its success was discussed, among other case studies within the medical and telecommunications industries. 

Another talk was delivered by Professor Granstrand at Freie Universität in Berlin on May 28. 

The invitation to Professor Granstrand’s second Leverhulme Trust Lecture, delivered at the Department of Engineering at University of Cambridge on May 2.

Glossary available

The glossary from Ove Granstrand’s book Evolving Properties of Intellectual Capitalism: Patents and Innovations for Growth and Welfare is now available here. This glossary contains many of the key concepts from the book as well as several other publications from the research group. Make sure to check it out if you are interested to learn more about the field of innovation and intellectual property management!

Seminar on IP strategy in ecosystems

On May 29 we were happy to host Mingjin Guo from University of Cambridge for a seminar on IP strategy. More specifically, Mingjin presented her PhD research on the coevolution of IP strategy and innovation ecosystems, a topic that is of much interest for our research group (see for example our Long Range Planning publication on this topic here). We thank Mingjin for a very interesting seminar and wish her best of luck with finishing her PhD, before joining Boston Consulting Group in Beijing later this year.

Mingjin Guo, University of Cambridge

20 years apart!

“It will be highly interesting to see what roles innovation and IP will play in this geo-political game.”

A patent’s lifetime ago Ove Granstrand published The Economics and Management of IP, which turned out to be one of the most cited publications in the area. Since then he has worked on another book in the same area, that recently came out: The Evolving Properties of Intellectual Capitalism: Patents and Innovations for Growth and Welfare. Much has happened since then, and much more will happen in the 20 years to come. 

In this new book Ove tries with a Swedish outlook to put innovation and IP in the current context of a global economy, driven as fast as ever by new technologies and innovations with new IP savvy players from Asia joining in the driver’s seat, notably China, building up large portfolios of IP resources along with financial and physical ones. International competition has again turned into competition between economic systems – market-led capitalism as in the US against state-led capitalism as in China. It will be highly interesting to see what roles innovation and IP will play in this geo-political game. More and most importantly however, is to see how innovations and IP can be used to meet all the technology-related global challenges. Will capitalist institutions like markets, entrepreneurship and property rights as we know them be sufficient? Probably not. Will they even be necessary? Most likely, but evolved. So at the same time as the intellectual properties in the capitalist economy evolve, we have to evolve the properties of intellectual capitalism.